C. Mascaro et al., Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription, ARCH BIOCH, 374(2), 2000, pp. 286-292
The effects of acute treatment with fluvastatin, a hypocholesteremic drug,
on the mRNA levels of several regulatory enzymes of cholesterogenesis and o
f the LDL receptor were determined in rat liver. Fluvastatin increased the
hepatic mRNA levels for HMG-CoA reductase up to la-fold in 5 weeks of treat
ment at a daily dose of 6.3 mg/kg. The effect was less marked in cytosolic
HMG-CoA synthase, farnesyl-PP synthase, squalene synthetase, and LDL recept
or. SREBP-9 mRNA levels were also increased, but SREBP-1 were not. De novo
synthesis of cholesterol in several cultured cells was reduced by increasin
g concentrations of fluvastatin, and the IC50 values of fluvastatin in HepG
2, CV-1, and CHO cells were respectively 0.01, 0.05, and 0.1 mu M. When CHO
cells stably transfected with a chimeric gene composed of the promoter of
cytosolic HMG-CoA synthase and the CAT gene as a reporter were incubated wi
th fluvastatin, the CAT gene was overexpressed, an effect which was similar
to the cotransfection with the processed form of SREBP-1a, Both ALLN and f
luvastatin increased the transcriptional activity of cytosolic HMG-CoA synt
hase. Mutation in either SRE or NF-Y boxes abolished the increase in transc
riptional rate caused by fluvastatin in the promoter of cytosolic HMG-CoA s
ynthase, These results indicate that the increase in transcriptional activi
ty in the HMG-CoA synthase gene attributable to fluvastatin is a consequenc
e of the activation of the proteolytic cleavage of SREBPs by reduced levels
of intracellular cholesterol. (C) 2000 Academic Press.